Application of Three-dimensional Multi-imaging Combination in Brachytherapy of Cervical Cancer

Overview

Journal Radiol Med

Specialty Radiology

Date 2023 May 3

PMID 37138200

Authors

Zhaoming Zhang

Ning Zhang

Guanghui Cheng

Affiliations

Soon will be listed here.

Abstract

Background: Three-dimensional (3D) imaging has an important role in brachytherapy and the treatment of cervical cancer. The main imaging methods used in the cervical cancer brachytherapy include magnetic resonance imaging (MRI), computer tomography (CT), ultrasound (US), and positron emission tomography (PET). However, single-imaging methods have certain limitations compared to multi-imaging. The application of multi-imaging can make up for the shortcomings and provide a more suitable imaging selection for brachytherapy.

Purpose: This review details the situation and scope of existing multi-imaging combination methods in cervical cancer brachytherapy and provides a reference for medical institutions.

Materials And Methods: Searched the literature related to application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer in PubMed/Medline and Web of Science electronic databases. Summarized the existing combined imaging methods and the application of each method in cervical cancer brachytherapy.

Conclusion: The current imaging combination methods mainly include MRI/CT, US/CT, MRI/US, and MRI/PET. The combination of two imaging tools can be used for applicator implantation guidance, applicator reconstruction, target and organs at risk (OAR) contouring, dose optimization, prognosis evaluation, etc., which provides a more suitable imaging choice for brachytherapy.

Citing Articles

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix.

Manea E, Chitoran E, Rotaru V, Ionescu S, Luca D, Cirimbei C Bioengineering (Basel). 2024; 11(5).

PMID: 38790373 PMC: 11117609. DOI: 10.3390/bioengineering11050506.

Research on liver cancer segmentation method based on PCNN image processing and SE-ResUnet.

Zang L, Liang W, Ke H, Chen F, Shen C Sci Rep. 2023; 13(1):12779.

PMID: 37550341 PMC: 10406939. DOI: 10.1038/s41598-023-39240-0.

References

Small Jr W, Bacon M, Bajaj A, Chuang L, Fisher B, Harkenrider M . Cervical cancer: A global health crisis. Cancer. 2017; 123(13):2404-2412. DOI: 10.1002/cncr.30667. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Koh W, Abu-Rustum N, Bean S, Bradley K, Campos S, Cho K . Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019; 17(1):64-84. DOI: 10.6004/jnccn.2019.0001. View

Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan A . Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013; 87(1):111-9. DOI: 10.1016/j.ijrobp.2013.05.033. View

Viswanathan A, Creutzberg C, Craighead P, McCormack M, Toita T, Narayan K . International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys. 2010; 82(1):250-5. PMC: 3489266. DOI: 10.1016/j.ijrobp.2010.10.030. View

Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005; 74(3):235-45. DOI: 10.1016/j.radonc.2004.12.015. View

Schmid M, Nesvacil N, Potter R, Kronreif G, Kirisits C . Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?. Radiother Oncol. 2016; 120(3):467-472. DOI: 10.1016/j.radonc.2016.01.021. View

Hellebust T . Place of modern imaging in brachytherapy planning. Cancer Radiother. 2018; 22(4):326-333. DOI: 10.1016/j.canrad.2018.03.005. View

Polo A . Image fusion techniques in permanent seed implantation. J Contemp Brachytherapy. 2016; 2(3):98-106. PMC: 5104828. DOI: 10.5114/jcb.2010.16920. View

10.

Yang X, Rossi P, Jani A, Mao H, Zhou Z, Curran W . Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation. J Appl Clin Med Phys. 2017; 18(1):202-210. PMC: 5689894. DOI: 10.1002/acm2.12040. View

11.

Peach M, Trifiletti D, Libby B . Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion. Prostate Cancer. 2016; 2016:4754031. PMC: 4884850. DOI: 10.1155/2016/4754031. View

12.

Bowes D, Crook J, Araujo C, Batchelar D . Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy. Brachytherapy. 2012; 12(1):38-43. DOI: 10.1016/j.brachy.2012.03.007. View

13.

Tisseverasinghe S, Marban M, Crook J, Petrik D, Araujo C . Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy. Brachytherapy. 2021; 20(4):849-856. DOI: 10.1016/j.brachy.2021.03.005. View

14.

Dimopoulos J, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012; 103(1):113-22. PMC: 3336085. DOI: 10.1016/j.radonc.2011.12.024. View

15.

Potter R, Tanderup K, Schmid M, Jurgenliemk-Schulz I, Haie-Meder C, Fokdal L . MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021; 22(4):538-547. DOI: 10.1016/S1470-2045(20)30753-1. View

16.

Russo L, Lancellotta V, Micco M, Fionda B, Avesani G, Rovirosa A . Magnetic resonance imaging in cervical cancer interventional radiotherapy (brachytherapy): a pictorial essay focused on radiologist management. J Contemp Brachytherapy. 2022; 14(3):287-298. PMC: 9528844. DOI: 10.5114/jcb.2022.117727. View

17.

Phan T, Mula-Hussain L, Pavamani S, Pearce A, DSouza D, Patil N . The changing landscape of brachytherapy for cervical cancer: a Canadian practice survey. Curr Oncol. 2015; 22(5):356-60. PMC: 4608401. DOI: 10.3747/co.22.2562. View

18.

Grover S, Harkenrider M, Cho L, Erickson B, Small C, Small Jr W . Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2016; 94(3):598-604. DOI: 10.1016/j.ijrobp.2015.11.024. View

19.

Viswanathan A, Dimopoulos J, Kirisits C, Berger D, Potter R . Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007; 68(2):491-8. DOI: 10.1016/j.ijrobp.2006.12.021. View

20.

Hegazy N, Potter R, Kirisits C, Berger D, Federico M, Sturdza A . High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination. Acta Oncol. 2013; 52(7):1345-52. DOI: 10.3109/0284186X.2013.813068. View